GEHC Capital Lease Obligations from 2010 to 2025
| GEHC Stock | 81.66 0.66 0.81% |
Capital Lease Obligations | First Reported 2010-12-31 | Previous Quarter 425 M | Current Value 454.3 M | Quarterly Volatility 15.4 M |
Check GE HealthCare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GE HealthCare's main balance sheet or income statement drivers, such as Tax Provision of 641.5 M, Interest Income of 29 M or Discontinued Operations of 15.4 M, as well as many indicators such as Price To Sales Ratio of 1.31, Dividend Yield of 0.0011 or PTB Ratio of 2.48. GEHC financial statements analysis is a perfect complement when working with GE HealthCare Valuation or Volatility modules.
GEHC | Capital Lease Obligations |
Latest GE HealthCare's Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of GE HealthCare Technologies over the last few years. GE HealthCare Techno capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to GE HealthCare asset purchases. For example, GE HealthCare can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as GE HealthCare control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. GE HealthCare's Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GE HealthCare's overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
GEHC Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 428,081,250 | |
| Geometric Mean | 427,810,801 | |
| Coefficient Of Variation | 3.61 | |
| Mean Deviation | 10,040,625 | |
| Median | 433,000,000 | |
| Standard Deviation | 15,432,832 | |
| Sample Variance | 238.2T | |
| Range | 68.3M | |
| R-Value | (0.26) | |
| Mean Square Error | 238.1T | |
| R-Squared | 0.07 | |
| Significance | 0.33 | |
| Slope | (838,971) | |
| Total Sum of Squares | 3572.6T |
GEHC Capital Lease Obligations History
About GE HealthCare Financial Statements
GE HealthCare stakeholders use historical fundamental indicators, such as GE HealthCare's Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Although GE HealthCare investors may analyze each financial statement separately, they are all interrelated. For example, changes in GE HealthCare's assets and liabilities are reflected in the revenues and expenses on GE HealthCare's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in GE HealthCare Technologies. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 425 M | 454.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of GE HealthCare Correlation against competitors. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GE HealthCare. If investors know GEHC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GE HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.784 | Dividend Share 0.125 | Earnings Share 4.34 | Revenue Per Share | Quarterly Revenue Growth 0.022 |
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GE HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GE HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.